{"pub": "marketwatch", "url": "https://marketwatch.com/articles/teva-stock-opioid-settlement-trial-generic-drugs-51571318646", "downloaded_at": "2019-10-17 14:19:05.436076+00:00", "title": "Teva Stock Is Jumping on Reports of an Opioid Settlement, but Questions Remain", "language": "en", "text": "Shares of Teva Pharmaceutical Industries were up more than 5% Thursday morning amid news that the company has a deal to settle many of the opioid cases against it. But it may be too early for Teva investors to relax.\n\nIn the days before the start of a key opioid trial in Ohio, negotiations appear to be at full throttle, and major news outlets are reporting wildly divergent figures for how much Teva (ticker: TEVA) has offered to pay. Analysts are still struggling to figure out what it all means.\n\n...", "description": "Shares of Teva Pharmaceutical Industries were up nearly 3% in premarket trading on Thursday amid news that the company has a deal to settle many of the opioid cases against it.", "authors": ["Josh Nathan-Kazis"], "top_image": "https://asset.barrons.com/public/resources/images/ON-DG812_TEVA10_OR_20191017092933.jpg", "published_at": "2019-10-17"}